TrialJournal of cancer research and clinical oncology2023

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry.

Maher Hanoun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.